Review on chemogenomics approach: Interpreting antagonist activity of secreted frizzled-related protein 1 in glaucoma disease with in-silico docking

Current Topics in Medicinal Chemistry

Volumn 12, Issue 16, 2012, Pages 1834-1842

  Dave, Kirtan ^a   Panchal, Hetalkumar ^a  

^a SARDAR PATEL UNIVERSITY   (India)

Author keywords

Chemogenomics; Conserved rich domain (CRD); Docking; Drug design; sFRP1; Wnt signalling pathway

Indexed keywords

MYCAPEROXIDE H; NATURAL PRODUCT; SECRETED FRIZZLED RELATED PROTEIN 1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AQUEOUS HUMOR; ARTICLE; CHEMOGENOMICS; COMPUTER AIDED DESIGN; COMPUTER MODEL; GENOMICS; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MOLECULAR DOCKING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; WNT SIGNALING PATHWAY;

AMINO ACID SEQUENCE; GENOMICS; GLAUCOMA; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; WNT PROTEINS;

EID: 84875362653     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/156802612803989255     Document Type: Article

References (128)

1. Tudor, I. Oprea; Elebeoba E. May; Andrei Leitão Alexander Tropsha. In Chemoinformatics and Computational Chemical Biology, Jürgen Bajorath, ed.; Humana Press, 2011; Vol. 673, pp. 459-672.
2. Borodina, Y.; Filimonov, D.; Poroikov, V. SAR QSAR Environ. Res., 2002, 13, 433-443.
3. Mestres, J. Curr. Opin. Drug Discov. Devel., 2004, 7, 304-313.
4. Jain, A. N. Ligand-based structural hypotheses for virtual screening. J. Med. Chem., 2004, 47, 947-461.
5. Munteanu, C.R.; Fernandez-Blanco, E.; Seoane, J.A.; Izquierdo-Novo, P.; Rodriguez-Fernandez, J. A.; Prieto-Gonzalez, J.M.; Rabunal, J.R.; Pazos, A. Curr. Pharm. Des., 16, 2640-2655.
6. Hassan, S.A.; Gracia, L.; Vasudevan, G.; Steinbach, P.J. Methods Mol. Biol., 2005, 305, 451-492.
7. Klabunde, T. Chemogenomic approaches to drug discovery: similar receptors bind similar ligands. Br. J. Pharm., 2007, 152, 5-7.
8. Bender, A.; Young, D.W.; Jenkinsa, J.L. Serranoc, M.; Mikhailova, D.; Paul, A.C.; Davies, J.W. Comb. Chem. High Throughput Screen., 2007, 10, 719-731.
9. Andricopulo, A.D.; Montanari, C.A. Mini Rev. Med. Chem., 2005, 5, 585-593.
10. Tingjun, H.; Xiaojie, X. Recent development and application of virtual screening in drug discovery: an overview. Curr. Pharm. Des., 2004, 10, 1011-1033
11. Fuse, N. Genetic bases for glaucoma. Tohoku J. Exp. Med., 2010, 221, 1-10.
12. Haefner, B. Drugs from the deep: marine natural products as drug candidates. Drug Discov. Today, 2003, 8, 536-544.
13. Jongejan, A.; de Graaf, C.; Vermeulen, N.P.; Leurs, R.; de Esch, I.J. The Role and Application of In Silico Docking in Chemical Genomics Research. Methods Mol. Biol., 2005, 310, 63-91.
14. Schafferhans, A.; Klebe, G. J. Mol. Biol., 2001, 307, 407-427.
15. Olah, M.; Bologa, C.; Oprea, T.I. An automated PLS search for biologically relevant QSAR descriptors. J. Comput. Aided Mol. Des., 2004, 18, 437-49.
16. del Val, C.; Mehrle, A.; Falkenhahn, M.; Seiler, M.; Glatting, K.H.; Poustka, A.; Suhai, S.; Wiemann, S. High-throughput protein analysis integrating bioinformatics and experimental assays. Nucleic Acids Res., 2004, 32, 742-748.
17. Bock, J.R.; Gough, D.A. A new method to estimate ligand-receptor energetics. Mol. Cell Proteomics, 2002, 1, 904-910.
18. Brune, T.; Tripti, G.; Sadiq, H.; John, S.; Barry, S. K.; Peter, V.N.B.; Gary S.S.; Jane B.L. Expression of secreted frizzled related protein 1, a Wnt antagonist, in brain, kidney, and skeleton is dispensable for normal embryonic development. J. Cell. Physiol., 2008, 217, 113-126.
19. Sparks, T.C.; Crouse, G.D.; Durst, G. Natural products as insecticides: the biology, biochemistry and quantitative structure-activity relationships of spinosyns and spinosoids. Pest Manag. Sci., 2001, 57, 896-905.
20. Ahn, S.K. A bioinformatics-based approach for the prediction and identification of novel proteins potentially involved in phosphorylation signalling pathways. Int. J. Mol. Med., 2003, 12, 391-397.
21. Jones, P.H. Cholesterol: precursor to many lipid disorders. Am. J. Manag. Care., 2001, 7, S289-298.
22. Adjei, A.A. Blocking oncogenic Ras signaling for cancer therapy. J. Natl. Cancer Inst., 2001, 93, 1062-1074.
23. Altmann, M. Reinterpreting network measures for models of disease transmission. Soc. Networks, 1993, 15, 1-17.
24. Galli, L.M.; Barnes., T.; Cheng., T.; Acosta., L.; Anglade, A.; Willert, K.; Nusse, R.; Burrus, L.W. Differential inhibition of Wnt-3a by Sfrp-1, Sfrp-2, and Sfrp-3. Developmental Dynamics, 2006, 235, 681-690.
25. Shastry, B.S. Genetic diversity and medicinal drug response in eye care. Graefe's Arch. Clin. Exp. Ophthalmol., 2010, 248, 1057-1061.
26. Robb, U.; de Iongh, H.E.A.; Gary, R. Hime WNT/Frizzled signaling in eye development and disease. Front. Biosci., 2006, 11, 2442-2464.
27. Wang., W.-H.; McNatt., L. G.; Pang., I.-H. Increased expression of the WNT antagonist sFRP-1 in glaucoma elevates intraocular pressure J. Clin. Investig., 2008, 118, 1056-1064.
28. Yoshiaki, K.; Robert, K. Secreted antagonists of the Wnt signalling pathway. J. Cell Sci., 2003, 116, 2627-2634.
29. Lavergne, E.; Hendaoui, I.; Coulouarn, C.; Ribault, C.; Leseur, J.; Eliat, P-A.; Mebarki, S.; Corlu, A.; Clé ment, B.; Musso, O. Blocking Wnt signaling by SFRP-like molecules inhibits in vivo cell proliferation and tumor growth in cells carrying active β-catenin. Oncogene, 2011, 30, 423-433.
30. Wawrzak, D.; Métioui, M.; Willems, E.; Hendrickx, M.; de Genst, E.; Leyns, L. Wnt3a binds to several sFRPs in the nanomolar range. Biochem. Biophys. Res. Commun., 2007, 357, 1119-1123.
31. Zhang, Z.; Grigorov, M.G. Similarity networks of protein binding sites. Proteins, 2006, 62, 470-478.
32. Paola Bovolenta; Pilar Esteve; Ruiz;, J.M.; Elsa Cisneros. Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease. J. Cell Sci., 2008, 121, 737-746.
33. Robb, U.d.I.; Helen, E.A.; Gary, R.H. WNT/Frizzled signaling in eye development and disease. Front. Biosci., 2006, 11, 2442-2464.
34. J Caprioli, R.M. Glaucoma is a neuronal disease. Eye, 2007, 21, S6-S10.
35. Moore, W.J.; Kern, J.C.; Bhat, R.; Thomas, C.J.; Fukayama, S.; Goljer, I.; Krishnamurthy, G.L.R.; Nogle, M.L.; Pitts, K.; Stauffer, B.; Trybulski, E.J.; Welmaker, G.S.; Wilson, M.; Bodine, P.V.N. Modulation of Wnt signaling through inhibition of secreted frizzled-related protein I (sFRP-1) with N-substituted piperidinyl diphenylsulfonyl sulfonamides. J. Med. Chem., 2009, 52, 105-116.
36. Phuwapraisirisan, P.; Matsunaga, S.; Fusetani, N.; Chaitanawisuti, N.; Kritsanapuntu, S.; Menasveta, P. Mycaperoxide H, a new cytotoxic norsesterterpene peroxide from a Thai marine sponge Mycale sp. J. Nat. Prod., 2003, 66, 289-291.
37. Espadaler, J.; Romero-Isart, O.; Jackson, R.M.; Oliva, B. Prediction of protein-protein interactions using distant conservation of sequence patterns and structure relationships. Bioinformatics, 2005, 21, 3360-3368.
38. Haefner, B. A model for NF-kappa B regulation by GSK-3 beta. Drug disco. today, 2003, 8(23), 1062-1063.
39. Baker, E.N.; Arcus, V.L.; Lott, J.S. Protein structure prediction and analysis as a tool for functional genomics. Appl. Bioinformatics, 2003, 2, S3-10.
40. Bock, J.R.; Gough, D.A. Predicting protein--protein interactions from primary structure. Bioinformatics, 2001, 17, 455-460.
41. Katoh, Y.; Katoh, M. Hedgehog signaling, epithelial-tomesenchymal transition and miRNA (review). Int. J. Mol. Med., 2008, 22(3), 271-275.
42. Stoddard, B.L.; Koshland, D.E. Jr. Prediction of the structure of a receptor-protein complex using a binary docking method. Nature, 1992, 358, 774-776.
43. Chakrabarti, R.; Klibanov, A.M.; Friesner, R.A. Computational prediction of native protein ligand-binding and enzyme active site sequences. Proc. Natl. Acad. Sci. U S A., 2005, 102, 10153-10158.
44. Gonzales-Diaz, H.; Gia, O.; Uriarte, E.; Hernadez, I.; Ramos, R.; Chaviano, M.; Seijo, S.; Castillo, J.A.; Morales, L.; Santana, L.; Akpaloo, D.; Molina, E.; Cruz, M.; Torres, L.A.; Cabrera, M.A. Markovian chemicals "in silico" design (MARCH-INSIDE), a promising approach for computer-aided molecular design I: discovery of anticancer compounds. J. Mol. Model, 2003, 9, 395-407.
45. Lewis, R.A. A general method for exploiting QSAR models in lead optimization. J. Med. Chem., 2005, 48, 1638-1648.
46. Strömbergsson, H.; Kleywegt, G.J. A chemogenomics view on protein-ligand spaces. BMC Bioinformatics, 2009, 10, S13.
47. Aloy, P.; Querol, E.; Aviles, F.X.; Sternberg, M.J. Automated structure-based prediction of functional sites in proteins: applications to assessing the validity of inheriting protein function from homology in genome annotation and to protein docking. J. Mol. Biol., 2001, 311, 395-408.
48. Hansch, C.; Hoekman, D.; Leo, A.; Weininger, D.; Selassie, C.D. Chem-bioinformatics: comparative QSAR at the interface between chemistry and biology. Chem. Rev., 2002, 102, 783-812.
49. Edwards, Y.J.; Cottage, A. Bioinformatics methods to predict protein structure and function. A practical approach. Mol. Biotechnol., 2003, 23, 139-166.
50. Giuliani, E.; Lembo, S.; Sasso, V.; Sorrentino, L.; Silipo, C.; Vittoria, A. Synthesis, biological data and correlation analysis in a set of analgesic drugs. Farmaco Sci., 1983, 38, 847-864.
51. Ekins, S.; Rose, J. In silico ADME/Tox: the state of the art. J. Mol. Graph Model, 2002, 20, 305-309.
52. Cai, Y.D.; Zhou, G.P.; Chou, K.C. Predicting enzyme family classes by hybridizing gene product composition and pseudo-amino acid composition. J. Theor. Biol., 2005, 234, 145-149.
53. Barril, X.; Morley, S.D. Unveiling the full potential of flexible receptor docking using multiple crystallographic structures. J. Med. Chem., 2005, 48, 4432-4443.
54. Yildirim, M.A.; Goh, K.I.; Cusick, M.E.; Barabasi, A. L.; Vidal, M. Drug-target network. Nat. Biotech., 2007, 25, 1119-1126.
55. Liao, J.C.; Boscolo, R.; Yang, Y.L.; Tran, L.M.; Sabatti, C.; Roychowdhury, V.P. Network component analysis: reconstruction of regulatory signals in biological systems. Proc. Natl. Acad. Sci. U S A., 2003, 100, 15522-15527.
56. Dave, K.; Banerjee, A. Bioinformatics Analysis of Functional Relations Between CNPs Regions. Current Bioinformatics, 2011, 6, 122-128.
57. Bonetta, L. Gene expression: an expression of interest. Nature, 2006, 440, 1233-1237.
58. Austin, D.W.; Allen, M.S.; McCollum, J.M.; Dar, R.D.; Wilgus, J.R.; Sayler, G.S.; Samatova, N.F.; Cox, C.D.; Simpson, M.L. Gene network shaping of inherent noise spectra. Nature, 2006, 439, 608-611.
59. Goh, K.I.; Cusick, M.E.; Valle, D.; Childs, B.; Vidal, M.; Barabasi, A.L. The human disease network Proc. Natl. Acad. Sci. U S A., 2007, 104, 8685-8690.
60. Kanehisa, M.; Araki, M.; Goto, S.; Hattori, M.; Hirakawa, M.; Itoh, M.; Katayama, T.; Kawashima, S.; Okuda, S.; Tokimatsu, T.; Yamanishi, Y. KEGG for linking genomes to life and the environment. Nucleic Acids Res., 2008, 36, D480-484.
61. Kanehisa, M.; Goto, S.; Furumichi, M.; Tanabe, M.; Hirakawa, M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res., 2010, 38, D355-360.
62. Bailey, L.C., Jr.; Searls, D.B.; Overton, G.C. Analysis of ESTdriven gene annotation in human genomic sequence. Genome Res., 1998, 8, 362-376.
63. Bairoch, A.; Apweiler, R. The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000. Nucleic Acids Res., 2000, 28, 45-48.
64. Cline, M.S.; Smoot, M.; Cerami, E.; Kuchinsky, A.; Landys, N.; Workman, C.; Christmas, R.; Avila-Campilo, I.; Creech, M.; Gross, B.; Hanspers, K.; Isserlin, R.; Kelley, R.; Killcoyne, S.; Lotia, S.; Maere, S.; Morris, J.; Ono, K.; Pavlovic, V.; Pico, A. R.; Vailaya, A.; Wang, P. L.; Adler, A.; Conklin, B. R.; Hood, L.; Kuiper, M.; Sander, C.; Schmulevich, I.; Schwikowski, B.; Warner, G. J.; Ideker, T.; Bader, G. D. Integration of biological networks and gene expression data using Cytoscape. Nat. Protoc., 2007, 2, 2366-2382.
65. Englbrecht, C.C.; Facius, A. Bioinformatics challenges in proteomics. Comb. Chem. High Throughput Screen., 2005, 8, 705-715.
66. Roberts, P.M.; Hayes, W.S. Curr. Opin. Drug Discov. Devel., 2005, 8, 323-328.
67. Langer, T.; Eder, M.; Hoffmann, R.D.; Chiba, P.; Ecker, G.F. Arch. Pharm. (Weinheim), 2004, 337, 317-327.
68. Vedani, A.; Dobler, M.; Lill, M.A. Toxicol. Appl. Pharmacol., 2005, 207, 398-407.
69. Pietryga, D. Prevention and treatment of acute graft-vs.-host disease. Am. J. Pediatr. Hematol. Oncol., 1993, 15, 28-48.
70. Marijuan, P.C. Bionformation: untangling the networks of life. Biosystems, 2002, 64, 111-118.
71. Apostolakis, J.; Caflisch, A. Computational ligand design. Comb. Chem. High Throughput Screen., 1999, 2, 91-104.
72. Lehar, J.; Zimmermann, G.R.; Krueger, A.S.; Molnar, R.A.; Ledell, J.T.; Heilbut, A.M.; Short, G.F., 3rd; Giusti, L.C.; Nolan, G.P.; Magid, O.A.; Lee, M. S.; Borisy, A.A.; Stockwell, B.R.; Keith, C.T. Mol. Syst. Biol., 2007, 3, 80.
73. Frishman, D. knowledge-based selection of targets for structural genomics. Protein Eng., 2002, 15, 169-183.
74. Sripriya, S.; Uthra, S.; Sangeetha, R.; George, R.J.; Hemamalini, A.; Paul, P.G.; Amali, J.; Vijaya, L.; Kumaramanickavel, G. Low frequency of myocilin mutations in Indian primary open-angle glaucoma patients. Clin. Genet., 2004, 65, 333-337.
75. Kimura, A.; Ando, E.; Fukushima, M.; Koga, T.; Hirata, A.; Arimura, K.; Ando, Y.; Negi, A.; Tanihara, H. Secondary glaucoma in patients with familial amyloidotic polyneuropathy. Arch. Ophthalmol., 2003, 121, 351-356.
76. Liu, H.; Mohamed, O.; Dufort, D.; Valerie, A.W. Characterization of Wnt signaling components and activation of the Wnt canonical pathway in the murine retina. Developmental Dynamics, 2003, V 227, 323-334.
77. Liu, H; Mohamed, O; Dufort, D; Wallace, V.A. Characterization of Wnt signaling components and activation of the Wnt canonical pathway in the murine retina. Dev. Dyn., 2003, 227, 323-234.
78. Clevers., H. Wnt/beta-catenin signaling in development and disease. Cell, 2006, 127, 473-479.
79. Huang, H-C.; Klein, P. S. The Frizzled family: receptors for multiple signal transduction pathways. Genome Biol., 2004, 234.
80. Esteve, P.; Trousse, F.; Rodríguez, J.; Bovolenta, P. SFRP1 modulates retina cell differentiation through a beta-catenin-independent mechanism. J. Cell. Sci., 2003, 116, 2471-2481.
81. Nakajima, H.; Itob. M.; Morikawa, Y.; Komori, T.; Fukuchi, Y.; Shibatad, F.; Okamotoa, S.; Kitamurad, T. Wnt modulators, SFRP-1, and SFRP-2 are expressed in osteoblasts and differentially regulate hematopoietic stem cells. Biochem. Biophys. Res. Commun., 2009, 390, 65-70.
82. Chen, Y.; Stump, R.J.; Lovicu, F. J; Mc Avoy, J.W. Expression of Frizzleds and secreted frizzled-related proteins (Sfrps) during mammalian lens development. Int. J. Dev. Biol., 2004, 48, 867-877.
83. Esteve, P.; Lopez-Rios, J.; Bovolenta, P. SFRP1 is required for the proper establishment of the eye field in the medaka fish. Mech. Dev., 2004, 121, 687-701.
84. Kima, H-S.; Shina, J.; Kima, S.H.; Chuna, H-S.; Kima, J-D.; Kima, Y-S.; Kima, M-J.; Rheeb, M.; Yeoa S-Y.; Huha, T-L. Eye field requires the function of Sfrp1 as a Wnt antagonist. Neurosci. Lett., 2007, 414, 26-29.
85. Leimeister, C.; Bach, A.; Gessler, M. Developmental expression patterns of mouse sFRP genes encoding members of the secreted frizzled related protein family. Mech. Dev., 1998, 75, 29-42.
86. Bafico, A.; Gazit, A.; Pramila. T.; Paul, W.F.; Yaniv, A.; Stuart, A. Developmental expression patterns of mouse sFRP genes encoding members of the secreted frizzled related protein family. J. Biol. Chem., 1999, 274, 16180-16187.
87. Ramesh, A.B.; Barbara, S.; Barry, S.; K.; Peter V.N. Bodine. Structure-function analysis of secreted frizzled-related protein-1 for its Wnt antagonist function. J. Cell. Biochem., 2007, 102, 1519-1528.
88. Katoh, M.; Katoh, M. WNT signaling pathway and stem cell signaling network. Clin. Cancer Res., 2007, 13, 4042-4045.
89. Jones, S.E.; Jomary, C. Secreted Frizzled-related proteins: searching for relationships and patterns. BioEssays, 2002, 24, 811-820.
90. Jaspard, B.; Thierry Couffinhala; Pascale Dufourcqa; Catherine Moreaua; Cécile Duplàaa. Expression pattern of mouse sFRP-1 and mWnt-8 gene during heart morphogenesis. Mech. Dev., 2000, 90, 263-267.
91. Amir Rattner; Jen-Chih Hsieh; Philip M. Smallwood; Debra J. Gilbert; Neil G. Copeland; Nancy A. Jenkins; Nathans. A family of secreted proteins contains homology to the cysteine-rich ligandbinding domain of frizzled receptors. J. Proc. Natl. Acad. Sci. USA., 1997, 94, 2859-2863.
92. Arnold, K.; Florian Kiefer; Jürgen Kopp; James N.D. Battey; Michael Podvinec; John D. Westbrook; Helen M. Berman; L.B.; Schwede, T. The Protein Model Portal. J. Struct. Funct. Genomics., 2009, 10. 1-8
93. Paul, A.B.; Lawrence, A.K.; Robert, M.; Sternberg, M.J.E. Enhancement of protein modeling by human intervention in applying the automatic programs 3D-JIGSAW and 3D-PSSM. Proteins, 2001, 5, 39-46
94. Nielsen, M.; Lundegaard, C.; Lund, O.; Petersen, T.N. CPHmodels-3.0--remote homology modeling using structure-guided sequence profiles. Nucl. Acids Res., 2010, 38, W576-W581.
95. Kiefer, F.; Arnold, K.; M. Künzli; Bordoli, L.; Schwed, T. The SWISS-MODEL Repository and associated resources. Nucl. Acids Res., 2009, 37, 387-392.
96. Chen, C-C.; Hwang, J-K.; Yang, J-M. (PS)2: protein structure prediction server. Nucl. Acids Res., 2006, 34, W152-W157.
97. Pieper, U.; Eswar, N.; Braberg, H.; Madhusudhan, M. S.; Davis, F.P.; Stuart, A.C.; Mirkovic, N.; Rossi, A.; Marti-Renom, M.A.; Fiser, A.; Webb, B.; Greenblatt, D.; Huang, C.C.; Ferrin, T.E.; Sali, A. MODBASE, a database of annotated comparative protein structure models, and associated resources. Nucleic Acids Res., 2004, 32, D217-222.
98. Pieper, U.; Eswar, N.; Stuart, A.C.; Ilyin, V.A.; Sali, A. MODBASE, a database of annotated comparative protein structure models. Nucleic Acids Res., 2002, 30, 255-259.
99. Petrey, D.; Honig, B. Protein structure prediction: inroads to biology. Mol. Cell, 2005, 20, 811-819.
100. Bent Petersen; Thomas Nordahl Petersenl; Pernille Andersen Morten Nielsen; Claus Lundegaard. A generic method for assignment of reliability scores applied to solvent accessibility predictions. BMC Struct. Biol., 2009, 9, 1-10.
101. Baxter, S.M.; Fetrow, J.S. Sequence-and structure-based protein function prediction from genomic information. Curr. Opin. Drug Discov. Devel., 2001, 4, 291-295.
102. Smyth, M. S.; Martin, J.H.J. x Ray crystallography. Mol. Path, 2000, 53, 8-12.
103. Khadikar, P.V.; Sharma, V.; Karmarkar, S.; Supuran, C.T. Novel use of chemical shift in NMR as molecular descriptor: a first report on modeling carbonic anhydrase inhibitory activity and related parameters. Bioorg. Med. Chem. Lett., 2005, 15, 931-936.
104. Dror, O.; Benyamini, H.; Nussinov, R.; Wolfson, H. Multiple structural alignment by secondary structures: algorithm and applications. J. Protein Sci., 2003, 12, 2492-2507.
105. Xiang, Z. Advances in homology protein structure modeling. Curr. Protein Pept. Sci., 2006, 7, 217-227.
106. Vakser, I.A. Protein docking for low-resolution structures Protein Eng., 1995, 8, 371-377.
107. Ai, N.; DeLisle, R.K.; Yu, S.J.; Welsh, W.J. Computational models for predicting the binding affinities of ligands for the wild-type androgen receptor and a mutated variant associated with human prostate cancer. Chem. Res. Toxicol., 2003, 16, 1652-1660.
108. Bairoch, A.; Apweiler, R.; Wu, C.H.; Barker, W.C.; Boeckmann, B.; Ferro, S.; Gasteiger, E.; Huang, H.; Lopez, R.; Magrane, M.; Martin, M.J.; Natale, D.A.; O'Donovan, C.; Redaschi, N.; Yeh, L.S. The Universal Protein Resource (UniProt). Nucleic Acids Res., 2005, 33, D154-159.
109. Berman, H.M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T.N.; Weissig, H.; Shindyalov, I.N.; Bourne, P.E. The Protein Data Bank. Nucleic Acids Res., 2000, 28, 235-242.
110. Altschul, S.F.; Gish, W.; Miller, W.; Myers, E.W.; Lipman, D.J. Basic local alignment search tool. J. Mol. Biol., 1990, 215, 403-410.
111. Lemmen, C.; Lengauer, T. Computational methods for the structural alignment of molecules. J. Comput. Aided. Mol. Des., 2000, 14, 215-232.
112. Vriend, G. WHAT IF: A molecular modeling and drug design program. J. Mol. Graph, 1990, 8, 52-56.
113. Melo, F.D.D.; Depiereux, E.; Feytmans, E. ANOLEA: a www server to assess protein structures. Proc. Int. Conf. Intell. Syst. Mol. Biol., 1997, 5, 187-190.
114. von Grotthuss, M.; Pas, J.; Wyrwicz, L.; Ginalski, K.; Rychlewski, L. Application of 3D-Jury, GRDB, and Verify3D in fold recognition. Proteins, 2003, 53, Suppl 6, 418-23.
115. Lüthy, R.; Bowie, J.U.; Eisenberg, D. Assessment of protein models with three-dimensional profiles. Nature, 1992, 356, 83-85.
116. R. A. Laskowski; M. W. MacArthur; D. S. Moss; J. M. Thornton. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst., 1993, 26, 283-291
117. Colovos, C.; Yeates, T.O. Verification of protein structures: patterns of nonbonded atomic interactions. Protein Science, 1993, 2, 1511-1519.
118. Dann, C.E.; Hsieh, J-C.; Rattner, A.; Sharma, D.; Nathans, J.; Leahy, D.J. Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains. Nature, 2001, 412, 86-90.
119. Pieper, U.; Eswar, N.; Ben, M. W.; Eramian, D.; Kelly, L.; Barkan, D.T.; Carter, H.; Mankoo, P.; Karchin, R.; Marc, A. Marti-Renom; Davis, F.P.; Sali, A. MODBASE, a database of annotated comparative protein structure models and associated resources. Nucleic Acids Res., 2009, 37, D347-D354
120. G. Gopalan; M.M. Thwin; P. Gopalakrishnakone; K. Swaminathan. Structural and pharmacological comparison of daboiatoxin from Daboia russelli siamensis with viperotoxin F and vipoxin from other vipers. Acta Cryst., 2007, D63, 722-729.
121. Chong, J.M.; Uren, A.; Rubin, J. S.; Speicher, D.W. Disulfide bond assignments of secreted Frizzled-related protein-1 provide insights about Frizzled homology and netrin modules. J. Biol. Chem., 2002, 277, 5134-5144.
122. Ben-Zeev, E.; Berchanski, A.; Heifetz, A.; Shapira, B.; Eisenstein, M. Prediction of the unknown: inspiring experience with the CAPRI experiment. Proteins, 2003, 52, 41-46.
123. Muryshev, A.E.; Tarasov, D.N.; Butygin, A.V.; Butygina, O.Y.; Aleksandrov, A.B.; Nikitin, S.M. A novel scoring function for molecular docking. J. Comput. Aided Mol. Des., 2003, 17, 597-605.
124. Tovchigrechko, A.; Vakser, I.A. GRAMM-X public web server for protein-protein docking. Nucl. Acids Res., 2006, 34, W310-W314.
125. Chen, R.; Weng, Z. A novel shape complementarity scoring function for protein-protein docking. Proteins, 2003, 51, 397-408.
126. Macindoe, L.M.G.; Venkatraman, V.; Devignes, M-D.; Ritchie, D.W., HexServer: an FFT-based protein docking server powered by graphics processors. Nucl. Acids Res., 2010, 38, W445-W449.
127. Kaiser, J. Science resources. Chemists want NIH to curtail database. Science, 2005, 308, 774.
128. Schüttelkopf, A.W.; van Aalten, D.M.F. Acta Cryst., 2004, D60, 1355-1363.